GlassScriptPhysician profile
Eric L Fernandez
NPI 1326052887
$3,806.77
in general payments reported to CMS, 2019-2025
38 companies · $845 in 2025
The $845 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $154 · 2021: $321 · 2022: $386 · 2023: $536 · 2024: $1,039 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,420.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $559.94 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $474.25 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Otsuka America Pharmaceutical, INC. | $280.77 | 2020-2025 | Rexulti, Abilify Mycite |
| Glaxosmithkline, LLC. | $254.11 | 2019-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $244.52 | 2019-2025 | Zepbound, Mounjaro, Kisunla |
| Pfizer INC. | $204.06 | 2019-2025 | |
| Novo Nordisk INC | $203.33 | 2021-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $176.28 | 2021-2023 | Freestyle Libre 3 |
| Abbvie INC. | $151.41 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $136.31 | 2019-2025 | |
| Amgen INC. | $114.25 | 2019-2024 | Repatha, Otezla |
| Teva Pharmaceuticals USA, INC. | $92.75 | 2019-2024 | Austedo Xr |
| Radius Health, INC. | $82.68 | 2019 | |
| Merck Sharp & Dohme LLC | $77.04 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Lundbeck LLC | $71.35 | 2024-2025 | Rexulti |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.